Topic Archives: Bio-Treat


  • $PIRS > Pieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of Directors

  • $HALO Halozyme Announces First Clinical Dosing In Bristol-Myers Squibb's Phase 1 Trial Of BMS-986179 With Enhanze┬« Tech...

  • Always be a little kinder than necessary. ~ J.M. Barrie

  • $MBRX Moleculin Announces Positive Data on WP1066 in Pre-Clinical Trials

  • $CUR Neuralstem Announces Publication of a Study Showing Benefits of Neural Stem Cell (NSC) Transplantation in a Mouse M...

  • Psychedelic psilocybin therapy for depression granted Breakthrough Therapy status by FDA

  • $NDRA Form 4 filed

  • $AUPH > Aurinia Pharmaceuticals to Release Third Quarter Financial Results and General Business Updates on November 8, 2...

  • Trump drug pricing speech tomorrow 2PM will focus on Medicare Part B drugs --> $IBB $XBI $REGN TY

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info